Principal Securities, Inc. Humacyte, Inc. Transaction History
Principal Securities, Inc.
- $5.32 Trillion
- Q2 2025
A detailed history of Principal Securities, Inc. transactions in Humacyte, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 15 shares of HUMA stock, worth $23. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 250
94.0%
Holding current value
$23
Previous $1.26 Million
97.55%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding HUMA
# of Institutions
169Shares Held
54.4MCall Options Held
1.1MPut Options Held
808K-
Black Rock Inc. New York, NY7.14MShares$11.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$10.9 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$6.85 Million0.0% of portfolio
-
Center Book Partners LP Greenwich, CT3.43MShares$5.35 Million0.42% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$4.6 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $161M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...